FT Health Discusses Cancer, Features Interview With Hugh Pullen Of European Medicines Verification Organisation

FT Health: Combating cancer; Brexit and E.U. medicine verification
The latest issue of the Financial Times’ weekly global health newsletter discusses efforts to address cancer, the world’s second leading cause of death, and features an interview with Hugh Pullen, president of the European Medicines Verification Organisation, discussing the launch of its new system involving the whole medical supply chain across Europe. The newsletter also provides a round-up of global health-related news stories (Dodd, 2/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.